These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4117438)

  • 1. Evaluation of a polyene macrolide: nystatin.
    Theodorides P; Bourke JB; Griffin JP
    Proc R Soc Med; 1972 Feb; 65(2):130-1. PubMed ID: 4117438
    [No Abstract]   [Full Text] [Related]  

  • 2. A double blind trial of a polyene macrolide--nystatin--in the treatment of benign prostatic hyperplasia in man.
    Bourke JB; Griffin JP; Theodorides P
    Br J Urol; 1974 Aug; 46(4):463-6. PubMed ID: 4137500
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prostatic hypertrophy treated with antimycotics. An orientation study].
    Aalkjaer V
    Ugeskr Laeger; 1970 Aug; 132(34):1556-8. PubMed ID: 4097058
    [No Abstract]   [Full Text] [Related]  

  • 4. Pills for the benign prostate. Trial designs.
    Castro JE
    Proc R Soc Med; 1972 Feb; 65(2):126-7. PubMed ID: 4117435
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of benign prostatic hyperplasia -- TURP versus greenlight laser vaporization].
    Bachmann A; Kuntz R
    Aktuelle Urol; 2007 Sep; 38(5):363-7. PubMed ID: 17953038
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of polyene macrolid compounds on plasma cholesterol and luteinizing hormone in man.
    Lunglmayr G; Spona J
    Int Urol Nephrol; 1973 Apr; 5(2):223-7. PubMed ID: 4129950
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment.
    Lowe FC
    Urology; 2009 Sep; 74(3):609; author reply 609-10. PubMed ID: 19716911
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical treatment of enlarged prostate.
    Br Med J; 1971 Dec; 4(5788):638-9. PubMed ID: 4109163
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of alpha 1-blockade in benign prostatic hyperplasia.
    Brawer MK
    J Clin Pharmacol; 1993 Sep; 33(9):891-5. PubMed ID: 7693769
    [No Abstract]   [Full Text] [Related]  

  • 10. Transurethral incision of the prostate for the treatment of benign prostatic hyperplasia.
    Jønler M; Bruskewitz RC
    Semin Urol; 1994 Aug; 12(3):156-60. PubMed ID: 7527920
    [No Abstract]   [Full Text] [Related]  

  • 11. Haloprogin and nystatin therapy for cutaneous candidiasis. Comparison of the efficacy of haloprogin and nystatin therapy.
    Carter VH; Olansky S
    Arch Dermatol; 1974 Jul; 110(1):81-2. PubMed ID: 4608934
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind comparison of clotrimazole and nystatin vaginal tablets in candida vaginitis.
    Marks HJ
    Postgrad Med J; 1974 Jul; 50 Suppl 1():105-8. PubMed ID: 4619451
    [No Abstract]   [Full Text] [Related]  

  • 13. [Side-effects and occurrence of yeast-like fungi in patients on oral treatment with tetracycline-nystatin].
    Bjurwill B; Frisk A
    Nord Med; 1968 Dec; 80(50):1695-8. PubMed ID: 4906210
    [No Abstract]   [Full Text] [Related]  

  • 14. Benign prostatic hyperplasia. Age and type of treatment.
    Bono AV; Fava C
    J Urol (Paris); 1995; 101(1):50-2. PubMed ID: 7545731
    [No Abstract]   [Full Text] [Related]  

  • 15. Current management and future trends in benign prostatic hyperplasia (BPH).
    Fitzpatrick JM
    Ir Med J; 1997 Nov; 90(7):256, 258. PubMed ID: 10036815
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current methods in the treatment of prostatic hyperplasia].
    Kontturi M
    Nord Med; 1993; 108(4):107-10. PubMed ID: 7683132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial of gestronol hexanoate (SH582) in benign prostatic hypertrophy.
    Gengell JC; Miller IM; Roberts JB
    Proc R Soc Med; 1972 Feb; 65(2):130. PubMed ID: 4117437
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of nystatin topical cream in the management of cutaneous candidiasis in infants.
    Alban J
    Curr Ther Res Clin Exp; 1972 Apr; 14(4):158-61. PubMed ID: 4623594
    [No Abstract]   [Full Text] [Related]  

  • 19. [Round-table discussion on the topic: prostatic hypertrophy].
    Langenbecks Arch Chir; 1972; 332():461-4. PubMed ID: 4119017
    [No Abstract]   [Full Text] [Related]  

  • 20. Benign prostatic hyperplasia (BPH) therapy: when? how? why? the take-home message.
    Marberger M
    J Urol (Paris); 1995; 101(1):56-7. PubMed ID: 7545734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.